Exploring the mechanisms of serum miRNA in obesity-related kidney injury
1General Hospital of the Northern Theater Command (CN), Shenyang, China. 523231628@qq.com.
Abstract:
Obesity, as a growing public health problem worldwide, is closely related to the development of various chronic diseases, including kidney damage. Obesity not only affects an individual's metabolic capacity but also leads to notable changes in kidney structure and function. Recent studies have found that serum miRNAs are important in obesity and its related complications, making them potential biomarkers and treatment targets. Serum miRNAs might affect kidney function by regulating processes such as cell proliferation, apoptosis, inflammation, and fibrosis. However, there are still some gaps in current research, such as the specific ways miRNAs work and how they relate to obesity-related kidney damage not being fully understood. This review looks at how obesity impacts kidney function by changing serum miRNAs, analyzes the relevant mechanisms, and summarizes current research progress to offer insights for future research and clinical treatments.
Insights
Obesity significantly impacts kidney function through alterations in serum microRNAs (miRNAs). Understanding these miRNA changes offers potential for new diagnostic and therapeutic strategies for obesity-related kidney damage.
Area of Science:
- Nephrology
- Endocrinology
- Molecular Biology
Background:
- Obesity is a global health crisis linked to chronic diseases, including kidney damage.
- Obesity alters metabolic capacity, kidney structure, and function.
- Serum microRNAs (miRNAs) are implicated in obesity and its complications, showing promise as biomarkers.
Purpose of the Study:
- To review the impact of obesity on kidney function via serum miRNA alterations.
- To analyze the underlying mechanisms of miRNA involvement in obesity-related kidney damage.
- To summarize current research and identify future directions for clinical treatment.
Main Methods:
- Literature review focusing on obesity, kidney function, and serum miRNAs.
- Analysis of studies investigating miRNA regulation in obesity-induced nephropathy.
- Synthesis of findings on miRNA roles in cellular processes affecting kidney health.
Main Results:
- Serum miRNAs are significantly altered in obesity and correlate with kidney damage.
- MiRNAs regulate key pathways in kidney injury, including proliferation, apoptosis, inflammation, and fibrosis.
- Specific miRNA roles and their precise mechanisms in obesity-related kidney disease require further elucidation.
Conclusions:
- Serum miRNAs represent crucial mediators in obesity-related kidney damage.
- Further research into specific miRNA functions can lead to novel diagnostic biomarkers.
- Targeting specific miRNAs may offer new therapeutic avenues for managing obesity-induced kidney disease.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Acute Kidney Injury II: Pathophysiology
External Anatomy of the Kidney
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
MicroRNAs
MicroRNAs


